These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 19601442)

  • 1. New drug information: Toviaz.
    Physician Assistants' Prescribing Reference
    JAAPA; 2009 Jun; 22(6):12. PubMed ID: 19601442
    [No Abstract]   [Full Text] [Related]  

  • 2. Fesoterodine (toviaz) for overactive bladder.
    Med Lett Drugs Ther; 2009 May; 51(1311):34-5. PubMed ID: 19417719
    [No Abstract]   [Full Text] [Related]  

  • 3. Efficacy and tolerability of fesoterodine in older and younger subjects with overactive bladder.
    Kraus SR; Ruiz-Cerdá JL; Martire D; Wang JT; Wagg AS
    Urology; 2010 Dec; 76(6):1350-7. PubMed ID: 20974482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tolterodine causes measurable restoration of urethral sensation in women with urge urinary incontinence.
    Kenton K; Lowenstein L; Brubaker L
    Neurourol Urodyn; 2010 Apr; 29(4):555-7. PubMed ID: 19771598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of tolterodine in nonneurogenic voiding dysfunction.
    Babu R
    Indian Pediatr; 2006 Nov; 43(11):980-3. PubMed ID: 17151401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does urodynamic verification of overactive bladder determine treatment success? Results from a randomized placebo-controlled study.
    Malone-Lee JG; Al-Buheissi S
    BJU Int; 2009 Apr; 103(7):931-7. PubMed ID: 19281469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Re: safety and tolerability of tolterodine for the treatment of overactive bladder in men with bladder outlet obstruction.
    Schaefer W
    J Urol; 2006 Nov; 176(5):2311-2; author reply 2312-3. PubMed ID: 17070326
    [No Abstract]   [Full Text] [Related]  

  • 8. Toviaz approved for overactive bladder.
    Traynor K
    Am J Health Syst Pharm; 2008 Dec; 65(23):2184. PubMed ID: 19020177
    [No Abstract]   [Full Text] [Related]  

  • 9. Patient-selected goals in overactive bladder: a placebo controlled randomized double-blind trial of transdermal oxybutynin for the treatment of urgency and urge incontinence.
    Cartwright R; Srikrishna S; Cardozo L; Robinson D
    BJU Int; 2011 Jan; 107(1):70-6. PubMed ID: 20626389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Response to fesoterodine in patients with an overactive bladder and urgency urinary incontinence is independent of the urodynamic finding of detrusor overactivity.
    Nitti VW; Rovner ES; Bavendam T
    BJU Int; 2010 May; 105(9):1268-75. PubMed ID: 19889062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changing treatments for overactive bladder.
    Waine E; Stott M
    Nurs Times; 2008 Oct 14-20; 104(41):45-8. PubMed ID: 18979960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patient-optimized doses of fesoterodine improve bladder symptoms in an open-label, flexible-dose study.
    Wyndaele JJ; Goldfischer ER; Morrow JD; Gong J; Tseng LJ; Choo MS
    BJU Int; 2011 Feb; 107(4):603-11. PubMed ID: 20860648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fesoterodine for the treatment of overactive bladder.
    Belavic JM
    Nurse Pract; 2009 Aug; 34(8):14-5. PubMed ID: 19638887
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparison of fesoterodine and tolterodine extended release for the treatment of overactive bladder: a head-to-head placebo-controlled trial.
    Herschorn S; Swift S; Guan Z; Carlsson M; Morrow JD; Brodsky M; Gong J
    BJU Int; 2010 Jan; 105(1):58-66. PubMed ID: 20132103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Overactive bladder. When it's pressing, immediate help is indicated].
    Widhalm S
    MMW Fortschr Med; 2008 May; 150(20):44-5. PubMed ID: 18605642
    [No Abstract]   [Full Text] [Related]  

  • 16. [Overactive bladder. New anticholinergic drug controls urinary urge].
    MMW Fortschr Med; 2004 Jul; 146(27-28):51. PubMed ID: 15526670
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment of men with lower urinary tract symptoms and overactive bladder.
    Young JG; Subramonian K
    JAMA; 2007 Mar; 297(11):1192-3; author reply 1193. PubMed ID: 17374809
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment of men with lower urinary tract symptoms and overactive bladder.
    Bell WA; Amarshi N
    JAMA; 2007 Mar; 297(11):1192; author reply 1193. PubMed ID: 17374810
    [No Abstract]   [Full Text] [Related]  

  • 19. Fesoterodine for the treatment of overactive bladder.
    Tzefos M; Dolder C; Olin JL
    Ann Pharmacother; 2009 Dec; 43(12):1992-2000. PubMed ID: 19920160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Durability of treatments for overactive bladder.
    Dasgupta P
    Int J Clin Pract; 2010 Apr; 64(5):528-9. PubMed ID: 20456203
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.